Public annual accounts

Dr. GHYSELINCK ASTRID financials

Name: Dr. GHYSELINCK ASTRID financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Dr. GHYSELINCK ASTRID, with comparable measures and links to available source documents.

Company overview

Registry number

0889000941

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

Latest movements for Dr. GHYSELINCK ASTRID

2025 versus 2024

Operating line: €151,509
EBITDA: €150,858
Total assets: €734,617
Equity: €703,733

EBITDA margin +99.6% · Equity ratio +95.8%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€151,509	€150,858	€734,617	€703,733	-
202431 Dec 2024	€136,359	€135,728	€617,446	€591,985	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202531 Dec 2025

€151,509

€150,858

€734,617

€703,733

202431 Dec 2024

€136,359

€135,728

€617,446

€591,985